PASSIVE FINGER HYPEREXTENSION AS A PREDICTION FACTOR OF PROGRESSION AT DUPUYTREN DISEASE
The paper is devoted to our technique for determination of elasticity of palmar aponeurosis in Dupuytren disease patients from measurements of the passive hyperextension of fingers from the neutral position. Aim of the study: development of the objective method for prediction of possible progression in Dupuytren disease patients in different terms. Material and methods. Results of measurement of the average value of passive hyperextension of fingers from the neutral position in patients of the control group (960 measurements in palms of the both hands: 560 in men and 400 in women of different age) and the main group (771 measurements in fingers of the both hands, in particular, 629 measurements in men and 142 measurements in women) served as materials for the study. Results. Significant differences were revealed in the average value of passive hyperextension of fingers from the neutral position in patients of the main group with I degree of clinical manifestation of the Dupuytren disease. The obtained results allow us to predict, to a certain degree, the progression of the main disease and the development of possible relapses from the data on elasticity of palmar aponeurosis.
Keywords
болезнь Дюпюитрена,
пассивная гиперэкстензия пальцев,
прогноз,
прогрессирование,
Dupuytren disease,
passive hyperextension of fingers,
prediction,
progressionAuthors
| Golubev I.O. | Peoples’ Friendship University of Russia (RUDN University) | |
| Ulishchenko A.A. | Peoples’ Friendship University of Russia (RUDN University) | dr.ales@yahoo.com |
Всего: 2
References
Lanting R., Broekstra D.C., Werker P.M. et al. A systematic review and meta-analysis on the prevalence of Dupuytren disease in the general population of western countries. Plast. Reconstr. Surg. 2014; 133(3): 593-603. DOI: 10.1097/01.prs.0000438455.37604.0f.
Lucas G., Brichet A., Roquelaure Y., Leclerc A., Descatha A. Dupuytren's disease: personal factors and occupational exposure. Am J Ind Med. 2008; 51(1): 9-15. DOI: 10.1002/ajim.20542.
Hart M.G., Hooper G. Clinical associations of Dupuytren’s disease. Postgraduate Medical Journal. 2005; 81(3): 425-28. DOI: 10.1136/pgmj.2004.027425.
Loos B., Puschkin V., Horch R.E. 50 years experience with Dupuytren's contracture in the Erlangen University Hospital - A retrospective analysis of 2919 operated hands from 1956 to 2006. Musculoskelet. Disord. 2007; 4(1): 8-60. DOI: 10.1186/1471-2474-8-60.
Warwick D., Tomas A., Bayat A. Dupuytren's disease: overview of a common connective tissue disease with a focus on emerging treatment options. Int. Clin. Rheumatol. 2012; 7(3): 309-23. DOI: 10.2147/TCRM.S8591.
Larson D., Jerosch-Herold C. Clinical effectiveness of postoperative splinting after surgical release of Dupuytren’s contracture: a systematic review. Musculoskelet. Disord. 2008; 9(1): 104-09. DOI: 10.1186/1471-2474-9- 104.
Kan H.J., Selles R.W., van Nieuwenhoven C.A. et al. Percutaneous aponeurotomy and lipofilling (PALF) versus limited fasciectomy in patients with primary Dupuytren’s contracture: prospective, randomized, controlled trial. Plast. Reconstr. Surg. 2016; 137(6): 1800-12. DOI: 10.1097/PRS.0000000000003537. В помощь практическому врачу 47 Вопросы реконструктивной и пластической хирургии № 3 (66) сентябрь’ 2018
Lipman M.D., Carstensen S.E., Deal D.N. Trends in the treatment of Dupuytren disease in the United States between 2007 and 2014. Hand (NY). 2017; 12(1): 13-20. DOI: 10.1177/1558944716647101.
Ball C., Izadi D., Verjee L.S., Chan J. Systematic review of non-surgical treatments for early Dupuytren’s disease. Musculoskelet. Disord. 2016; 17(1): 345-52. DOI: 10.1186/s12891-016-1200-y.
